Displaying 181 - 200 of 249 results

New Pilot Program Will Mentor Leaders and Advance Women’s Health

https://www.niams.nih.gov/about/about-the-director/letter/new-pilot-program-will-mentor-leaders-and-advance-womens-health

We are pleased to announce a new and exciting program designed to create a more robust cadre of researchers dedicated to women’s health research. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the NIH Office of Research on Women’s Health (ORWH) are partnering to launch a pilot program to support and train research scholars by helping them acquire and hone team science leadership and mentoring skills. The Team Science Leadership Scholars Program (LSP) will be funded by ORWH and embedded within the Accelerating Medicines Partnership® Autoimmune and Immune-Mediated Diseases (AMP® AIM) program, which NIAMS and ORWH both support1.

Freedom of Information Act (FOIA)

https://www.niams.nih.gov/about/foia

Overview The FOIA, 5 U.S.C. 552, provides individuals with a right to access to records in the possession of the Federal government. The government may withhold information pursuant to the nine exemptions and three exclusions contained in the Act. If you have questions regarding FOIA requests pending with the National

Accessibility Statement

https://www.niams.nih.gov/about/accessibility

Accessibility The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) of the National Institutes of Health (NIH) is making every effort to ensure that the information available on our website is accessible to all. If you use special adaptive equipment to access the Web and encounter problems when

JAK Inhibition in Down Syndrome

https://www.niams.nih.gov/jak-inhibition-down-syndrome

Clinical Trials in the Spotlight Main Page The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports a range of clinical trials studying new and existing interventions for prevention and treatment of arthritis, musculoskeletal, and skin diseases. Investigators supported by the NIAMS need your help finding individuals to

Scientific Director of Intramural Research, Dr. John O'Shea, Elected to the U.S. National Academy of Sciences

https://www.niams.nih.gov/newsroom/announcements/scientific-director-intramural-research-dr-john-oshea-elected-us-national

On May 2, 2023, NIAMS Scientific Director of Intramural Research, Dr. John O’Shea, was elected to the U.S. National Academy of Sciences at the conclusion of the Academy’s 160 th annual meeting. This designation – considered one of the highest honors that a scientist can achieve – recognizes distinguished and continuing achievements in original research. In addition to this latest accolade, Dr. O’Shea has received numerous prizes, including the Howley Prize for Research in Arthritis, the Ross Prize in Molecular Medicine, the Millstein Prize from the International Cytokine and Interferon Society, the AAI-Steinman Award for Human Immunology, the ASCI-Harrington Prize

The NIAMS Training Program (T32)

https://www.niams.nih.gov/grants-funding/research-training-and-career-development-programs/funding-opportunities/t32_program

Goal of NIAMS Institutional Training Awards NIAMS funds the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) (PA-23-048) to enable institutions to support pre-doctoral and postdoctoral research training for individuals in the fields of arthritis and musculoskeletal and skin diseases. The NIAMS T32 program's primary

Typically materials from NIAMS that are more than 5 years old will be archived.